T<sub>4</sub>N (+)Ⅲ期食管胸中下段癌3DRT长期生存分析

doi:10.3760/cma.j.issn.1004-4221.2017.01.006

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (841 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract

Objective To observe the long-term survival and adverse reactions in patients with stage T₄N (+) Ⅲ middle and lower thoracic esophageal carcinoma undergoing intensity-modulated radiotherapy (IMRT). Methods From 2004 to 2010, 300 patients with stage T₄N (+) Ⅲ middle and lower thoracic esophageal carcinoma, consisting of 202 treated with three-dimensional conformal radiotherapy (3DCRT) and 98 treated with IMRT, were enrolled as subjects. All patients received conventionally fractionated radiotherapy with a prescribed dose of 60 Gy. The long-term survival and adverse reactions were compared between patients treated with the two different radiotherapy regimens. The survival rates were calculated by the Kaplan-Meier method and analyzed by the log-rank test. Results The 5-and 7-year sample sizes were 239 and 120, respectively. The 3DCRT group had significantly lower 1-, 3-, 5-, and 7-year local control (LC) and overall survival (OS) rates than the IMRT group (64.4% vs. 68.3%, 40.6% vs. 55.3%, 38.3% vs. 51.9%, 34.2% vs. 51.9%, P=0.048;54.5% vs. 63.3%, 19.8% vs. 34.7%, 14.7% vs. 24.4%, 10.9% vs. 20.3%, P=0.013). The stratified analysis showed that for patients older than 65 years, with the length of esophageal lesion>8.0 cm before radiotherapy, the largest diameter of esophageal lesion in computed tomography image>4.6 cm, gross tumor volume (GTV)>60 cm³, metastases to adjacent tissues or organs, stage N₂, and without chemotherapy, the IMRT group had a significantly higher OS rate than the 3DCRT group (P=0.022,0.003,0.022,0.034,0.016,0.044,0.047). The GTVD_min and GTVD₁₀₀ were significantly higher in the IMRT group than in the 3DCRT group (P=0.000,0.000), while the D_max of the spinal cord was significantly lower in the IMRT group than in the 3DCRT group (P=0.000). Compared with the 3DCRT group, the IMRT group had a significantly higher incidence of acute radiation-induced esophagitis, particularly grade 1-2 esophagitis (P=0.000). The mortality rate caused by local tumor was significantly higher in the 3DCRT group than in the IMRT group (P=0.039). Conclusions In the treatment of locally advanced middle and lower thoracic esophageal carcinoma, IMRT is safe and effective;it significantly improves the LC rate and long-term survival without severe toxicity to normal tissues. The results of this retrospective study need to be confirmed by prospective randomized controlled studies.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Ren Xuejiao
	Wang Lan
	Han Chun
	Tian Hua
	Liu Lihong
	Li Xiaoning
	Gao Chao

Key words： Esophageal neoplasms/radiotherapy Radiotherapy,three-dimensional Radiotherapy,intensity-modulated Prognosis

Received: 23 May 2016

Corresponding Authors: Han Chun,Email:hanchun2006@126.com

Cite this article:

Ren Xuejiao,Wang Lan,Han Chun et al. Long term survival analysis of middle and lower thoracic esophageal carcinoma of stage T₄N (+) treated with 3DRT[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 29-34.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2017.01.006 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2017/V26/I1/29

[1] 中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌的临床分期标准(草案)[J].中华放射肿瘤学杂志,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001.
China non operative treatment of esophageal cancer clinical staging expert group. Standard for clinical staging of non operative treatment for esophageal cancer (Draft)[J].Chin J Radiat Oncol,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001.
[2] 万钧,肖爱勤,高淑珍,等.食管癌放疗后近期疗效评价标准——附1000例分析[J].中国放射肿瘤学,1989,3(4):205-207.
Wan J,Xiao AQ,Gao SZ,et al. Criteria of evaluation of immediate response of radiation therapy for esophageal carcinoma——Report on 1000 patients[J].Chin Radiat Oncol,1989,3(4):205-207.
[3] Wang D,Yang Y,Zhu J,et al.3D-conformal RT,fixed-field IMRT and RapidArc,which one is better for esophageal carcinoma treated with elective nodal irradiation[J].Technol Cancer Res Treat,2011,10(5):487-494.DOI:10.7785/tcrt.2012.500225.
[4] 白文文,周志国,宋玉芝,等.颈段食管癌三维适形与IMRT的剂量学及临床对比研究[J].中华放射医学与防护杂志,2014,34(12):919-921.DOI:10.3760/cma.j.issn.0254-5098.2014.12.010.
Bai WW,Zhou ZG,Song YZ,et al. Cervical esophageal cancer with three-dimensional conformal IMRT dosimetry and clinical comparative study[J].Chin J Radiol Med Protect,2014,34(12):919-921.DOI:10.3760/cma.j.issn.0254-5098.2014.12.010.
[5] 葛小林,孙新臣,陈文湛,等.胸上段食管癌IMRT和3DCRT剂量学研究[J].中国医学物理学杂志,2010,27(2):1708-1711,1720.DOI:10.3969/j.issn.1005-202X.2010.02.003.
Ge XL,Sun XC,Chen WZ,et al. Dosimetry study of IMRT and 3DCRT radiotherapies for patients with upper esophageal carcinoma[J].Chin J Med Phys,2010,27(2):1708-1711,1720.DOI:10.3969/j.issn.1005-202X.2010.02.003.
[6] 李定杰,刘海龙,毛荣虎,等.胸中段、胸下段食管癌适形放疗和IMRT的剂量学研究[J].中国辐射卫生,2011,20(3):265-267.DOI:10.13491/j.cnki.issn.1004-714x.2011.03.071.
Li DJ,Liu HL,Mao RH,et al. Comparison of dose distribution between 3DCRT and IMRT in middle thoracic and under thoracic esophageal carcinoma[J].Chin J Radiol Health,2011,20(3):265-267.DOI:10.13491/j.cnki.issn.1004-714x.2011.03.071.
[7] 姜世文,赵佳莹,钟文,等.食管癌适形与IMRT技术剂量参数比较的Meta分析[J].现代肿瘤医学,2016,24(4):566-571.DOI:10.3969/j.issn.1672-4992.2016.04.017.
Jiang SW,Zhao JY,Zhong W,et al. Dosimetric parameters between three-dimensional conformal radiotherapy and intensity modulated radiotherapy for esophageal cancer radiotherapy:a Meta-analysis[J].J Mod Oncol,2016,24(4):566-571.DOI:10.3969/j.issn.1672-4992.2016.04.017.
[8] 王玉祥,王军,王祎,等.食管癌伴区域淋巴结转移三维适形与IMRT疗效初步比较[J].中华放射肿瘤学杂志,2011,20(6):489-493.DOI:10.3760/cma.j.issn.1004-4221.2011.06.013.
Wang YX,Wang J,Wang Y,et al. Prognosis comparison of three-dimensional conformal radiotherapy/intensity modulated radiation therapy for esophageal carcinoma with localregional lymph node metastasis[J].Chin J Radiat Oncol,2011,20(6):489-493.DOI:10.3760/cma.j.issn.1004-4221.2011.06.013.
[9] 孔洁,李晓宁,韩春,等.792例食管癌三维技术放疗的疗效分析[J].中华放射肿瘤学杂志,2012,21(5):421-424.DOI:10.3760/cma.j.issn.1004-4221.2012.05.007.
Kong J,Li XN,Han C,et al. Treatment outcomes of 792 cases of esophageal carcinoma patients treated with three-dimensional radiotherapy[J].Chin J Radiat Oncol,2012,21(5):421-424.DOI:10.3760/cma.j.issn.1004-4221.2012.05.007.
[10] Gaspar LE,Winter K,Kocha WI,et al. A phase Ⅰ/Ⅱ study of external beam radiation,brachytherapy,and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207):final report[J].Cancer,2000,88(5):988-995.
[11] Ling TC,Slater JM,Nookala P,et al. Analysis of intensity-modulated radiation therapy (IMRT),proton and 3D conformal radiotherapy (3DCRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients[J].Cancers,2014,6(4):2356-2368.DOI:10.3390/cancers6042356.
[12] 王澜,李晓宁,吕冬婕,等.肺低剂量区体积预测急性放射性肺炎价值探讨[J].中华放射肿瘤学杂志,2010,19(4):296-300.DOI:10.3760/cma.j.issn.1004-4221.2010.04.005.
Wang L,Li XN,L DJ,et al. Low dose volume of the lung in prediction of acute radiation pneumonitis[J].Chin J Radiat Oncol,2010,19(4):296-300.DOI:10.3760/cma.j.issn.1004-4221.2010.04.005.